GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis

Inflammation Research

Volumn 60, Issue 9, 2011, Pages 831-840

  Ooi, Makoto ^a   Nishiumi, Shin ^a   Yoshie, Tomoo ^a   Shiomi, Yuuki ^a   Kohashi, Michitaka ^a   Fukunaga, Ken ^b   Nakamura, Shiro ^b   Matsumoto, Takayuki ^b   Hatano, Naoya ^c   Shinohara, Masakazu ^c   Irino, Yasuhiro ^c   Takenawa, Tadaomi ^c   Azuma, Takeshi ^a   Yoshida, Masaru ^a,c  

^a KOBE UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amino acid; GC MS; Metabolomics; Ulcerative colitis

Indexed keywords

ALANINE; AMINO ACID; ASPARAGINE; ASPARTIC ACID; AZATHIOPRINE; CITRIC ACID; FUMARIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; INFLIXIMAB; ISOCITRIC ACID; ISOLEUCINE; LEUCINE; LYSINE; MALIC ACID; MERCAPTOPURINE; MESALAZINE; METHIONINE; PHENYLALANINE; PREDNISOLONE; PROLINE; PYROGLUTAMIC ACID; TACROLIMUS; THREONINE; TRICHLOROACETIC ACID; TRYPTOPHAN; TYROSINE; VALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COLON; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DIET THERAPY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MASS FRAGMENTOGRAPHY; PROTEIN EXPRESSION; REMISSION; SUPERNATANT; ULCERATIVE COLITIS; UPREGULATION;

ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; CITRIC ACID CYCLE; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; YOUNG ADULT;

EID: 80052062107     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0340-7     Document Type: Article

References (46)

1. DK Bonen JH Cho 2003 The genetics of inflammatory bowel disease Gastroenterology 124 521 536 12557156 10.1053/gast.2003.50045 1:CAS:528:DC%2BD3sXhsFOgs78%3D (Pubitemid 36169267)
2. JA Katz J Itoh C Fiocchi 1999 Pathogenesis of inflammatory bowel disease Curr Opin Gastroenterol 15 291 297 17023960 10.1097/00001574-199907000-00003 1:STN:280:DC%2BD28rpt1yjtw%3D%3D (Pubitemid 29377246)
3. Y Young MT Abreu 2006 Advances in the pathogenesis of inflammatory bowel disease Curr Gastroenterol 8 470 477 10.1007/s11894-006-0037-1 (Pubitemid 46017159)
4. H Lochs C Dejong F Hammarqvist X Hebuterne M Leon-Sanz T Schütz W van Gemert A van Gossum L Valentini H Lübke S Bischoff N Engelmann P Thul 2006 ESPEN guidelines on enteral nutrition: gastroenterology Clin Nutr 25 260 274 16698129 10.1016/j.clnu.2006.01.007 1:STN:280:DC%2BD28zktVGluw%3D%3D (Pubitemid 43811680)
5. M Homan RN Baldassano P Mamula 2005 Managing complicated Crohn's disease in children and adolescents Nat Clin Pract Gastroenterol Hepatol 2 572 579 16327836 10.1038/ncpgasthep0338
6. T Johnson S Macdonald SM Hill A Thomas MS Murphy 2006 Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial Gut 55 356 361 16162683 10.1136/gut.2004.062554 1:CAS:528:DC%2BD28Xis1Sjsbk%3D (Pubitemid 43268273)
7. T Yamamoto M Nakahigashi AR Saniabadi 2009 Review article: diet and inflammatory bowel disease-epidemiology and treatment Aliment Pharmacol Ther 30 99 112 19438426 10.1111/j.1365-2036.2009.04035.x 1:CAS:528:DC%2BD1MXptVarsbY%3D
8. T Matsui T Sakurai T Yao 2005 Nutritional therapy for Crohn's disease in Japan J Gastroenterol 40 25 31 15902960 10.1007/s00535-005-1675-z (Pubitemid 41349247)
9. CK Ameho AA Adjei EK Harrison K Takeshita T Morioka Y Arakaki E Ito I Suzuki AD Kulkarni A Kawajiri S Yamamoto 1997 Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis Gut 41 487 493 9391247 10.1136/gut.41.4.487 1:CAS:528:DyaK2sXntleltr8%3D (Pubitemid 27448780)
10. E Israeli E Berenshtein D Wengrower L Aptekar R Kohen G Zajicek E Goldin 2004 Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage Dig Dis Sci 49 1705 1712 15573931 10.1023/B:DDAS.0000043390.12150.8b 1:CAS:528:DC%2BD2cXnvFGrsLs%3D (Pubitemid 39335560)
11. M Giriş Y Erbil S Doǧru-Abbasoǧlu BT Yanik H Aliş V Olgaç GA Toker 2007 The effect of heme oxygenase-1 induction by glutamine on TNBS-induced colitis. The effect of glutamine on TNBS colitis Int J Colorectal Dis 22 591 599 17124609 10.1007/s00384-006-0238-y (Pubitemid 47097030)
12. M Vicario C Amat M Rivero M Moretó C Pelegrí 2007 Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis J Nutr 137 1931 1937 17634266 1:CAS:528:DC%2BD2sXos1Cktbg%3D (Pubitemid 47292741)
13. H Arndt F Kullmann F Reuss J Schölmerich KD Palitzsch 1999 Glutamine attenuates leukocyte endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat JPEN J Parenter Enteral Nutr 23 12 18 9888412 10.1177/014860719902300112 1:CAS:528:DC%2BD3cXlvFGgtLo%3D (Pubitemid 29016712)
14. J Basivireddy M Jakob KA Balasubramanian 2004 Oral glutamine attenuates indomethacin-induced small intestinal damage Clin Sci 107 281 289 15128285 10.1042/CS20030390 1:CAS:528:DC%2BD2cXmvVOnur8%3D (Pubitemid 39243887)
15. H Fillmann NA Kretzmann B San-Miguel S Llesuy N Marroni J González-Gallego MJ Tuñón 2007 Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat Toxicology 236 217 226 17543437 10.1016/j.tox.2007.04.012 1:CAS:528:DC%2BD2sXntFKntLc%3D (Pubitemid 46977112)
16. I Tsune K Ikejima M Hirose M Yoshikawa N Enomoto Y Takei N Sato 2003 Dietary glycine prevents chemical-induced experimental colitis in the rat Gastroenterology 125 775 785 12949723 10.1016/S0016-5085(03)01067-9 1:CAS:528:DC%2BD3sXnvVSiurc%3D (Pubitemid 37070695)
17. A Andou T Hisamatsu S Okamoto H Chinen N Kamada T Kobayashi M Hashimoto T Okutsu K Shimbo T Takeda H Matsumoto A Sato H Ohtsu M Suzuki T Hibi 2009 Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages Gastroenterology 136 564 574 19027739 10.1053/j.gastro.2008.09.062 1:CAS:528:DC%2BD1MXislOhtLc%3D
18. JT Bjerrum OH Nielsen YL Wang J Olsen 2008 Technology insight: metabonomics in gastroenterology-basic principles and potential clinical applications Nat Clin Pract Gastroenterol Hepatol 5 332 343 18431374 10.1038/ncpgasthep1125 (Pubitemid 351803604)
19. A Hirayama K Kami M Sugimoto M Sugawara N Toki H Onozuka T Kinoshita N Saito A Ochiai M Tomita H Esumi T Soga 2009 Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry Cancer Res 69 4918 4925 19458066 10.1158/0008-5472.CAN-08-4806 1:CAS:528:DC%2BD1MXmsFGks74%3D
20. A Sreekumar LM Poisson TM Rajendiran AP Khan Q Cao J Yu B Laxman R Mehra RJ Lonigro Y Li MK Nyati A Ahsan S Kalyana-Sundaram B Han X Cao J Byun GS Omenn D Ghosh S Pennathur DC Alexander A Berger JR Shuster JT Wei S Varambally C Beecher AM Chinnaiyan 2009 Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 457 910 914 19212411 10.1038/nature07762 1:CAS:528:DC%2BD1MXhslCnt70%3D
21. H Gao Q Lu X Liu H Cong L Zhao H Wang D Lin 2009 Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis Cancer Sci 100 782 785 19469021 10.1111/j.1349-7006.2009.01086.x 1:CAS:528:DC%2BD1MXlsFSrtro%3D
22. Marion JF, Rubin PH, Present DH. Differential diagnosis of chronic ulcerative colitis and Crohn's disease. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia: WB Saunders; 2000. p. 315-25.
23. D Rachmilewitz 1989 Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial BMJ 298 82 86 2563951 10.1136/bmj.298.6666.82 1:STN:280:DyaL1M7ltVOitg%3D%3D (Pubitemid 19032930)
24. J Myren IA Bouchier G Watkinson A Softley SE Clamp FT de Dombal 1984 The O.M.G.E. multinational inflammatory bowel disease survey 1976-1982. A further report on 2,657 cases Scand J Gastroenterol 19 1 27 (Pubitemid 14117461)
25. S Nishiumi M Shinohara A Ikeda T Yoshie N Hatano S Kakuyama S Mizuno T Sanuki H Kutsumi E Fukusaki T Azuma T Takenawa M Yoshida 2010 Serum metabolomics as a novel diagnostic approach for pancreatic cancer Metabolomics 6 518 528 10.1007/s11306-010-0224-9 1:CAS:528:DC%2BC3cXhtlKjtb7K
26. SG Matts 1961 The value of rectal biopsy in the diagnosis of ulcerative colitis Q J Med 30 393 407 14471445 1:STN:280:DyaF38%2Fnt12iug%3D%3D
27. Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T, Kondo Y, Furumatsu K, Shiomi H, Kutsumi H, Azuma T, Yoshida M. A GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis 2011 (in press) doi: 10.1002/ibd.21616.
28. F Fernández-Bañares E Cabré F González-Huix MA Gassull 1994 Enteral nutrition as primary therapy in Crohn's disease Gut 35 55 59 10.1136/gut.35.1-Suppl.S55
29. TA Lennie DO McCarthy RE Keesey 1995 Body energy status and the metabolic response to acute inflammation Am J Physiol 269 1024 1031
30. PR Ling BR Bistrian B Mendez NW Istfan 1994 Effects of systemic infusions of endotoxin, tumor necrosis factor, and, interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake Metabolism 43 279 284 8139474 10.1016/0026-0495(94)90093-0 1:CAS:528:DyaK2cXht1GmtrY%3D (Pubitemid 24100495)
31. HB Jijon T Churchill D Malfair A Wessler LD Jewell HG Parsons KL Madsen 2000 Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis Am J Physiol Gastointest Liver Physiol 279 641 651
32. A Cetinkaya E Bulbuloglu B Kantarceken H Ciralik EB Kurutas MA Buyukbese Y Gumusalan 2006 Effects of l-carnitine on oxidant/antioxidant status in acetic acid-induced colitis Dig Dis Sci 51 488 494 16614957 10.1007/s10620-006-3160-9 1:CAS:528:DC%2BD28XjsFyjtrk%3D
33. FC Edwards SC Truelove 1964 The course and prognosis of ulcerative colitis Gut 5 1 22 14127503 10.1136/gut.5.1.1 1:STN:280:DyaF2c%2FosFamtg%3D%3D
34. J Goh CA O'Morain 2003 Nutrition and adult inflammatory bowel disease Aliment Pharmacol Ther 17 307 320 12562443 10.1046/j.1365-2036.2003.01482.x 1:CAS:528:DC%2BD3sXitleht70%3D (Pubitemid 36259393)
35. F Rizzello P Gionchetti A Venturi M Campieri 2003 Review article: medical treatment of severe ulcerative colitis Aliment Pharmacol Ther 17 7 10 12786606 10.1046/j.1365-2036.17.s2.18.x (Pubitemid 36831452)
36. M Coëffier P Déchelotte 2005 The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome Nutr Rev 63 65 69 15762090 10.1111/j.1753-4887.2005.tb00123.x (Pubitemid 40250745)
37. G Wu SM Morris Jr 1998 Arginine metabolism: nitric oxide and beyond Biochem J 336 1 17 9806879 1:CAS:528:DyaK1cXotVGltrs%3D (Pubitemid 28532555)
38. F Wu T Dassopoulos L Cope A Maitra SR Brant ML Harris TM Bayless G Parmigiani S Chakravarti 2007 Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis Inflamm Bowel Dis 13 807 821 17262812 10.1002/ibd.20110 (Pubitemid 47203859)
39. J Olsen TA Gerds JB Seidelin C Csillag JT Bjerrum JT Troelsen OH Nielsen 2009 Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data Inflamm Bowel Dis 15 1032 1038 19177426 10.1002/ibd.20879
40. CA Solem EV Loftus Jr WJ Tremaine WS Harmsen AR Zinsmeister WJ Sandborn 2005 Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease Inflamm Bowel Dis 11 707 712 16043984 10.1097/01.MIB.0000173271.18319.53 (Pubitemid 41271173)
41. S Vermeire G Van Assche P Rutgeerts 2004 C-reactive protein as a marker for inflammatory bowel disease Inflamm Bowel Dis 10 661 665 15472532 10.1097/00054725-200409000-00026 (Pubitemid 39276479)
42. JE Lennard-Jones HE Lockhart-Mummery BC Morson 1968 Clinical and pathological differentiation of Crohn's disease and proctocolitis Gastroenterology 54 1162 1170 5656336 1:STN:280:DyaF1c3osVWntw%3D%3D
43. EJ Hoffenberg S Fidanza A Sauaia 1999 Serologic testing for inflammatory bowel disease J Pediatr 134 447 452 10190919 10.1016/S0022-3476(99)70202-7 1:STN:280:DyaK1M3gslSqsg%3D%3D (Pubitemid 30180626)
44. M Peeters S Joossens S Vermeire R Vlietinck X Bossuyt P Rutgeerts 2001 Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease Am J Gastroenterol 96 730 734 11280542 10.1111/j.1572-0241.2001.03613.x 1:STN:280:DC%2BD3M7ovFOktg%3D%3D (Pubitemid 32240723)
45. MC Dubinsky JJ Ofman M Urman SR Targan EG Seidman 2001 Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease Am J Gastroenterol 96 758 765 11280547 10.1111/j.1572-0241.2001.03618.x 1:STN:280:DC%2BD3M7ovFOkuw%3D%3D (Pubitemid 32240727)
46. WJ Sandborn EV Loftus Jr JF Colombel KA Fleming F Seibold HA Homburger B Sendid RW Chapman WJ Tremaine DK Kaul J Wallace WS Harmsen AR Zinsmeister SR Targan 2001 Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease Inflamm Bowel Dis 7 192 201 11515844 10.1097/00054725-200108000-00003 1:STN:280:DC%2BD3MvntFSiuw%3D%3D (Pubitemid 32776511)